Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial
Overview
Authors
Affiliations
Importance: Intensive lifestyle change (e.g., the Diabetes Prevention Program) and metformin reduce type 2 diabetes risk among patients with prediabetes. However, real-world uptake remains low. Shared decision-making (SDM) may increase awareness and help patients select and follow through with informed options for diabetes prevention that are aligned with their preferences.
Objective: To test the effectiveness of a prediabetes SDM intervention.
Design: Cluster randomized controlled trial.
Setting: Twenty primary care clinics within a large regional health system.
Participants: Overweight/obese adults with prediabetes (BMI ≥ 24 kg/m and HbA1c 5.7-6.4%) were enrolled from 10 SDM intervention clinics. Propensity score matching was used to identify control patients from 10 usual care clinics.
Intervention: Intervention clinic patients were invited to participate in a face-to-face SDM visit with a pharmacist who used a decision aid (DA) to describe prediabetes and four possible options for diabetes prevention: DPP, DPP ± metformin, metformin only, or usual care.
Main Outcomes And Measures: Primary endpoint was uptake of DPP (≥ 9 sessions), metformin, or both strategies at 4 months. Secondary endpoint was weight change (lbs.) at 12 months.
Results: Uptake of DPP and/or metformin was higher among SDM participants (n = 351) than controls receiving usual care (n = 1028; 38% vs. 2%, p < .001). At 12-month follow-up, adjusted weight loss (lbs.) was greater among SDM participants than controls (- 5.3 vs. - 0.2, p < .001).
Limitations: Absence of DPP supplier participation data for matched patients in usual care clinics.
Conclusions And Relevance: A prediabetes SDM intervention led by pharmacists increased patient engagement in evidence-based options for diabetes prevention and was associated with significantly greater uptake of DPP and/or metformin at 4 months and weight loss at 12 months. Prediabetes SDM may be a promising approach to enhance prevention efforts among patients at increased risk.
Trial Registration: This study was registered at clinicaltrails.gov (NCT02384109)).
Grujic-Vujmilovic D, Veljkovic K, Gavric Z, Popovic-Pejicic S Libyan J Med. 2024; 20(1):2437226.
PMID: 39676503 PMC: 11650698. DOI: 10.1080/19932820.2024.2437226.
Li E, Waters A, Cunningham A, Silverio A, Han J, Mills G Am J Lifestyle Med. 2024; 18(6):727-736.
PMID: 39507910 PMC: 11536499. DOI: 10.1177/15598276221123527.
Perceived Penalties for Sharing Patient Beliefs with Health Care Providers.
Marsh J, Asan O, Kleinberg S Med Decis Making. 2024; 44(6):617-626.
PMID: 39092564 PMC: 11346123. DOI: 10.1177/0272989X241262241.
Geta E, Terefa D, Hailu W, Olani W, Merdassa E, Dessalegn M PLoS One. 2024; 19(7):e0306296.
PMID: 39083503 PMC: 11290692. DOI: 10.1371/journal.pone.0306296.
Tseng E, Smith K, Clark J, Segal J, Marsteller J, Maruthur N BMJ Open Qual. 2024; 13(2).
PMID: 38839396 PMC: 11163602. DOI: 10.1136/bmjoq-2024-002752.